Perbedaan Faal Hemostasis Pada Pasien Penyakit Jantung Koroner Dengan Dan Tanpa Diabetes Mellitus Tipe 2 Dengan Menggunakan Tromboelastografi (Teg)
61
LAMPIRAN 1
Universitas Sumatera Utara
62
LAMPIRAN 2
LEMBAR PENJELASAN KEPADA CALON SUBJEK PENELITIAN
Selamat pagi/siang Bapak/Ibu, pada hari ini saya, dr.Brama Ihsan Sazli,
peserta Pendidikan Pasca Sarjana Ilmu Penyakit Dalam / Magister Klinik FK
USU Medan akan melakukan penelitian yang berjudul ” Perbandingan faal
hemostasis pada pasien penyakit jantung koroner dengan dan tanpa DM tipe 2
dengan menggunakan tromboelastografi ”. Dimana faal hemostasis ini merupakan
tingkat proses pembekuan darah bapak.
Anda bebas memilih keikutsertaan dalam penelitian ini tanpa paksaan dari
pihak manapun. Bila Anda sudah memutuskan untuk ikut, Anda juga bebas untuk
mengundurkan diri/ berubah pikiran setiap saat tanpa dikenakan denda atau pun
sanksi apapun.
Apabila Anda bersedia berpartisipasi dalam penelitian ini, Anda diminta
menandatangani lembar persetujuan untuk peneliti. Prosedur selanjutnya adalah:
1. Anda akan diwawancarai oleh peneliti untuk menanyakan identitas subjek,
riwayat penyakit, riwayat obat-obatan, dan riwayat kesehatan lain yang
berhubungan dengan penelitian ini.
2. Anda akan diminta untuk dilakukan pengambilan darah sebanyak 1 kali.
Pengambilan darah dilakukan sehari setelah dilakukan prosedur.
3. Pengambilan darah akan dilakukan oleh perawat yang berkompeten dan
telah terbiasa melakukan tindakan tersebut.
4. Sampel darah akan dibawa untuk dilakukan pemeriksaan.
Sebagai subjek penelitian, Anda berkewajiban mengikuti aturan atau
petunjuk penelitian seperti yang tertulis di atas. Bila ada yang belum jelas, Anda
dapat bertanya kepada peneliti.
Pada dasarnya, pengambilan darah hanya akan menyebabkan risiko
minimal. Risiko yang mungkin terjadi adalah lebam/kulit kebiruan atau sedikit
perdarahan pada daerah tempat pengambilan darah. Anda dapat menekan daerah
suntikan jika darah masih mengalir dan mengompres daerah suntikan jika terjadi
lebam/kulit kebiruan.
Segala biaya pemeriksaan laboratorium dan penyediaan obat menjadi
tanggung jawab peneliti. Bila masih terdapat pertanyaan atau keluhan sewaktu
penelitian ini berjalan, maka Bapak/Ibu dapat menghubungi saya pada:
Nama
: dr.Brama Ihsan Sazli
Alamat
: Jl. Gaperta no 188 Medan
Telepon
: 085296630320
Peneliti,
(dr.Brama Ihsan Sazli)
Universitas Sumatera Utara
63
LAMPIRAN 3
SURAT PERSETUJUAN SETELAH PENJELASAN
(INFORMED CONCERN )
Saya yang bertanda tangan dibawah ini :
Nama
:...........................................................................................
Alamat
:...........................................................................................
Umur
:........................ Tahun
Jenis Kelamin : Laki-laki/ Perempuan.
No Telp/HP :
Setelah mendapat penjelasan dari peneliti tentang kebaikan dan keburukan
prosedur penelitian ini , menyatakan secara sadar dan tanpa paksaan bersedia ikut
serta dalam penelitian” Perbandingan faal hemostasis pada pasien Diabetes
Mellitus tipe 2 dan Penyakit Jantung Koroner dengan menggunakan
tromboelastografi”.
Demikianlah surat persetujuan bersedia ikut dalam penelitian ini saya buat, untuk
dapat digunakan seperlunya.
…........................2015
Saksi
(…..........................................)
Medan,
Yang Memberi Pernyataan
(…..........................................)
Universitas Sumatera Utara
64
LAMPIRAN 4
KERTAS KERJA PROFIL PESERTA PENELITIAN
I.IDENTITAS PRIBADI
Nama
Tempat/Tanggal Lahir
Jenis Kelamin
Pendidikan Terakhir
Pekerjaan
Status
Telp/Hp:….............
:
Kode : X / Y
:
: Laki-laki/Perempuan.
:
:
:
Kawin/Belum
Kawin.
No
II.ANAMNESIS PENYAKIT DAN PENGOBATAN
Anamnesis Penyakit dan Terapi
1. Diabetes Mellitus / dalam terapi Diabetes mellitus
2. Hipertensi, kardiovaskular dan stroke
3. Penyakit kronis
4. Penyakit gangguan fungsi ginjal
5. Penyakit gangguan fungsi hati
6. Hamil/Menyusui/Terapi Hormonal
7. Perokok.
Ya
Tidak
III.PEMERIKSAAN FISIK
Tekanan Darah
: ….... mmHg.
Pemeriksaan Parameter Antrometri.
Parameter Antropometri
Berat Badan (kg)
Tinggi Badan (m2)
Indeks Massa Tubuh (kg/m2 )
Pre- Test
Post-Test
IV.PEMERIKSAAN LABORATORIUM
Rutin:
Hemostasis Konvensional:
V. Hasil Tromboelastografi:
Universitas Sumatera Utara
65
LAMPIRAN 5
Data Penelitian
Universitas Sumatera Utara
66
Keterangan:
Jenis Kelamin: 1: laki-laki
2: Wanita
Obese, Merokok, Dislipidemia, HT, Diabetes, riwayat keluarga, riwayat ACS,
Aspirin, Clopidogrel, Statin:
1: ya
2: tidak
Universitas Sumatera Utara
67
LAMPIRAN 6
Output Analisis
Tests of Normality
Kolmogorov-Smirnova
diabetes
usia
Statistic
1
df
.109
2
Shapiro-Wilk
Sig.
15
.120
26
Statistic
df
Sig.
.200
*
.972
15
.888
.200
*
.963
26
.461
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
Group Statistics
diabetes
usia
N
Mean
Std. Deviation
Std. Error Mean
1
15
56.80
9.428
2.434
2
26
56.46
6.243
1.224
Independent Samples Test
Levene's Test for Equality of
Variances
F
usia
t-test for Equality of Means
Sig.
Equal variances assumed
t
3.006
.091
Equal variances not assumed
df
.138
39
.124
21.219
Independent Samples Test
t-test for Equality of Means
Sig. (2-tailed)
usia
Mean Difference
Std. Error
Difference
Equal variances assumed
.891
.338
2.446
Equal variances not assumed
.902
.338
2.725
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
usia
Upper
Equal variances assumed
-4.608
5.285
Equal variances not assumed
-5.325
6.002
Crosstabs
sex * diabetes Crosstabulation
diabetes
1
2
Total
Universitas Sumatera Utara
68
sex
1
Count
Expected Count
2
12
24
36
13.2
22.8
36.0
3
2
5
1.8
3.2
5.0
Count
Expected Count
Total
Count
Expected Count
15
26
41
15.0
26.0
41.0
Chi-Square Tests
Value
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
Asymp. Sig. (2sided)
df
1.346a
.442
1.291
1
1
1
.246
.506
.256
1.313
41
1
.252
Exact Sig. (2sided)
Exact Sig. (1sided)
.336
.249
a. 2 cells (50,0%) have expected count less than 5. The minimum expected count is 1,83.
b. Computed only for a 2x2 table
Explore
Tests of Normality
Kolmogorov-Smirnova
diabetes
TDS
Statistic
df
Shapiro-Wilk
Sig.
1
.179
15
2
.191
26
Statistic
df
Sig.
*
.946
15
.460
.015
.933
26
.093
.200
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
T-Test
Group Statistics
diabetes
TDS
N
Mean
Std. Deviation
Std. Error Mean
1
15
127.00
18.689
4.826
2
26
131.81
19.291
3.783
Independent Samples Test
Levene's Test for Equality of
Variances
F
TDS
Equal variances assumed
t-test for Equality of Means
Sig.
.003
t
.959
Equal variances not assumed
df
-.777
39
-.784
30.127
Independent Samples Test
t-test for Equality of Means
Universitas Sumatera Utara
69
Sig. (2-tailed)
TDS
Std. Error
Difference
Mean Difference
Equal variances assumed
.442
-4.808
6.186
Equal variances not assumed
.439
-4.808
6.132
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
TDS
Upper
Equal variances assumed
-17.319
7.704
Equal variances not assumed
-17.328
7.713
Explore
diabetes
Tests of Normality
Kolmogorov-Smirnova
diabetes
HR
Statistic
1
df
.217
2
Shapiro-Wilk
Sig.
.113
Statistic
df
Sig.
15
.055
.843
15
.014
26
*
.963
26
.458
.200
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
Mann-Whitney Test
Ranks
iabetes
HR
N
Mean Rank
Sum of Ranks
1
15
21.93
329.00
2
26
20.46
532.00
Total
41
Test Statisticsb
HR
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
Exact Sig. [2*(1-tailed Sig.)]
181.000
532.000
-.380
.704
.718a
a. Not corrected for ties.
b. Grouping Variable: diabetes
Explore
Tests of Normality
Kolmogorov-Smirnova
diabetes
BMI
1
Statistic
.138
df
Shapiro-Wilk
Sig.
15
.200
Statistic
*
.918
df
Sig.
15
.178
Universitas Sumatera Utara
70
2
.123
.200*
26
.943
26
.160
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
T-Test
Group Statistics
diabetes
BMI
N
Mean
Std. Deviation
Std. Error Mean
1
15
25.4367
3.79212
.97912
2
26
25.5288
3.29004
.64523
Independent Samples Test
Levene's Test for Equality of
Variances
F
BMI
t-test for Equality of Means
Sig.
Equal variances assumed
t
.287
.595
Equal variances not assumed
df
-.082
39
-.079
26.049
Independent Samples Test
t-test for Equality of Means
Sig. (2-tailed)
BMI
Std. Error
Difference
Mean Difference
Equal variances assumed
.935
-.09218
1.12789
Equal variances not assumed
.938
-.09218
1.17260
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
BMI
Upper
Equal variances assumed
-2.37355
2.18919
Equal variances not assumed
-2.50228
2.31792
merokok * diabetes Crosstabulation
diabetes
1
Merokok
1
Count
Total
Total
12
24
36
13.2
22.8
36.0
3
2
5
Expected Count
1.8
3.2
5.0
Count
15
26
41
15.0
26.0
41.0
Expected Count
2
2
Count
Expected Count
Chi-Square Tests
Universitas Sumatera Utara
71
Value
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
Asymp. Sig. (2sided)
df
Exact Sig. (2sided)
1.346a
.442
1.291
1
1
1
.246
.506
.256
1.313
41
1
.252
Exact Sig. (1sided)
.336
.249
a. 2 cells (50,0%) have expected count less than 5. The minimum expected count is 1,83.
b. Computed only for a 2x2 table
hipertensi * diabetes Crosstabulation
diabetes
1
hipertensi
1
Count
Total
Total
19
29
10.6
18.4
29.0
5
7
12
Expected Count
4.4
7.6
12.0
Count
15
26
41
15.0
26.0
41.0
Expected Count
2
2
10
Count
Expected Count
Chi-Square Tests
Value
.189a
.006
.187
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
Asymp. Sig. (2sided)
df
1
1
1
Exact Sig. (2sided)
Exact Sig. (1sided)
.664
.938
.665
.730
.184
41
1
.668
a. 1 cells (25,0%) have expected count less than 5. The minimum expected count is 4,39.
b. Computed only for a 2x2 table
NPar Tests
Two-Sample Kolmogorov-Smirnov Test
Frequencies
diabetes
Merokok
N
1
15
2
26
Total
41
Test Statisticsa
merokok
Most Extreme Differences
Absolute
.123
Positive
.123
Universitas Sumatera Utara
.464
72
Negative
Kolmogorov-Smirnov Z
.000
.380
Asymp. Sig. (2-tailed)
.999
a. Grouping Variable: diabetes
NPar Tests
Two-Sample Kolmogorov-Smirnov Test
Frequencies
diabetes
Hipertensi
N
1
15
2
26
Total
41
Test Statisticsa
hipertensi
Most Extreme Differences
Absolute
.064
Positive
.064
Negative
Kolmogorov-Smirnov Z
.000
.198
Asymp. Sig. (2-tailed)
1.000
a. Grouping Variable: diabetes
riwACS * diabetes Crosstabulation
diabetes
1
riwACS
1
2
Total
2
Total
Count
11
9
20
Expected Count
7.3
12.7
20.0
4
17
21
Expected Count
7.7
13.3
21.0
Count
15
26
41
15.0
26.0
41.0
Count
Expected Count
Chi-Square Tests
Value
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
5.707a
4.263
5.874
Asymp. Sig. (2sided)
df
1
1
1
Exact Sig. (2sided)
Exact Sig. (1sided)
.017
.039
.015
.025
5.568
41
1
.018
a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 7,32.
b. Computed only for a 2x2 table
riwPCI * diabetes Crosstabulation
Universitas Sumatera Utara
.019
73
diabetes
1
riwPCI
1
2
Count
Total
5
6
11
Expected Count
4.0
7.0
11.0
Count
10
20
30
11.0
19.0
30.0
15
26
41
15.0
26.0
41.0
Expected Count
Total
2
Count
Expected Count
Chi-Square Tests
Value
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
Asymp. Sig. (2sided)
df
Exact Sig. (2sided)
.510a
.121
.501
1
1
1
.475
.728
.479
.497
41
1
.481
Exact Sig. (1sided)
.491
a. 1 cells (25,0%) have expected count less than 5. The minimum expected count is 4,02.
b. Computed only for a 2x2 table
NPar Tests
Two-Sample Kolmogorov-Smirnov Test
Frequencies
diabetes
riwPCI
N
1
15
2
26
Total
41
Test Statisticsa
riwPCI
Most Extreme Differences
Absolute
.103
Positive
.000
Negative
Kolmogorov-Smirnov Z
-.103
.316
Asymp. Sig. (2-tailed)
1.000
a. Grouping Variable: diabetes
aspirin * diabetes Crosstabulation
diabetes
1
aspirin
1
Count
Expected Count
2
Count
2
Total
7
11
18
6.6
11.4
18.0
8
15
23
Universitas Sumatera Utara
.359
74
Total
Expected Count
8.4
14.6
23.0
Count
15
26
41
15.0
26.0
41.0
Expected Count
Chi-Square Tests
Value
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
Asymp. Sig. (2sided)
df
Exact Sig. (2sided)
.073a
.000
.073
1
1
1
.786
1.000
.787
.072
41
1
.789
Exact Sig. (1sided)
1.000
.521
a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 6,59.
b. Computed only for a 2x2 table
Crosstabs
Case Processing Summary
Cases
Valid
N
clopidogrel * diabetes
Missing
Percent
41
N
100.0%
Total
Percent
N
0
.0%
2
Total
Percent
41
100.0%
clopidogrel * diabetes Crosstabulation
diabetes
1
clopidogrel
1
Count
Expected Count
2
Total
7
9
16
5.9
10.1
16.0
Count
8
17
25
Expected Count
9.1
15.9
25.0
Count
15
26
41
15.0
26.0
41.0
Expected Count
Chi-Square Tests
Value
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
Asymp. Sig. (2sided)
df
.581a
.185
.577
1
1
1
.446
.667
.448
.566
41
1
.452
Exact Sig. (2sided)
Exact Sig. (1sided)
.517
a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 5,85.
b. Computed only for a 2x2 table
Universitas Sumatera Utara
.332
75
statin * diabetes Crosstabulation
diabetes
1
statin
1
2
Total
5
6
11
Expected Count
4.0
7.0
11.0
Count
10
20
30
11.0
19.0
30.0
Expected Count
Total
2
Count
Count
Expected Count
15
26
41
15.0
26.0
41.0
Chi-Square Tests
Value
Asymp. Sig. (2sided)
df
.510a
.121
.501
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
1
1
1
Exact Sig. (2sided)
Exact Sig. (1sided)
.475
.728
.479
.491
.497
41
1
.359
.481
a. 1 cells (25,0%) have expected count less than 5. The minimum expected count is 4,02.
b. Computed only for a 2x2 table
Tests of Normality
Kolmogorov-Smirnova
diabetes
hb
Statistic
1
df
.160
2
Shapiro-Wilk
Sig.
15
.101
26
Statistic
df
Sig.
.200
*
.918
15
.178
.200
*
.963
26
.444
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
T-Test
Group Statistics
diabetes
hb
N
Mean
Std. Deviation
Std. Error Mean
1
15
13.0467
1.90108
.49086
2
26
14.7654
1.36057
.26683
Independent Samples Test
Levene's Test for Equality of
Variances
F
hb
Equal variances assumed
t-test for Equality of Means
Sig.
3.034
Equal variances not assumed
t
.089
df
-3.363
39
-3.076
22.401
Independent Samples Test
Universitas Sumatera Utara
76
t-test for Equality of Means
Sig. (2-tailed)
hb
Std. Error
Difference
Mean Difference
Equal variances assumed
.002
-1.71872
.51102
Equal variances not assumed
.005
-1.71872
.55869
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
hb
Upper
Equal variances assumed
-2.75235
-.68509
Equal variances not assumed
-2.87617
-.56126
Tests of Normality
Kolmogorov-Smirnova
diabetes
leukosit
Statistic
df
Shapiro-Wilk
Sig.
1
.169
15
2
.153
26
Statistic
df
Sig.
*
.929
15
.261
.118
.908
26
.024
.200
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
Mann-Whitney Test
Ranks
diabetes
leukosit
N
Mean Rank
Sum of Ranks
1
15
22.20
333.00
2
26
20.31
528.00
Total
41
Test Statisticsb
leukosit
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
Exact Sig. [2*(1-tailed Sig.)]
177.000
528.000
-.487
.626
.640a
a. Not corrected for ties.
b. Grouping Variable: diabetes
Tests of Normality
Kolmogorov-Smirnova
diabetes
platelet
1
Statistic
.151
df
Shapiro-Wilk
Sig.
15
.200
Statistic
*
df
.910
Sig.
15
.133
Universitas Sumatera Utara
77
2
.130
.200*
26
.968
26
.583
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
Group Statistics
diabetes
platelet
N
Mean
Std. Deviation
Std. Error Mean
1
15
311600.0000
1.06793E5
27573.93524
2
26
244000.0000
45128.26165
8850.38026
Independent Samples Test
Levene's Test for Equality of
Variances
F
platelet
Equal variances assumed
t-test for Equality of Means
Sig.
19.328
t
.000
Equal variances not assumed
df
2.837
39
2.334
16.933
Independent Samples Test
t-test for Equality of Means
Sig. (2-tailed)
platelet
Mean Difference
Std. Error
Difference
Equal variances assumed
.007
67600.00000
23825.25359
Equal variances not assumed
.032
67600.00000
28959.47402
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
platelet
Equal variances assumed
Equal variances not assumed
Upper
19408.87589
1.15791E5
6482.30258
1.28718E5
diabetes
Tests of Normality
Kolmogorov-Smirnova
diabetes
ureum
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.236
15
.025
.815
15
.006
2
.183
26
.024
.865
26
.003
a. Lilliefors Significance Correction
Mann-Whitney Test
Ranks
diabetes
ureum
N
Mean Rank
Sum of Ranks
1
15
25.77
386.50
2
26
18.25
474.50
Universitas Sumatera Utara
78
Ranks
diabetes
ureum
N
Mean Rank
Sum of Ranks
1
15
25.77
386.50
2
26
18.25
474.50
Total
41
Test Statisticsb
ureum
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
Exact Sig. [2*(1-tailed Sig.)]
123.500
474.500
-1.935
.053
.052a
a. Not corrected for ties.
b. Grouping Variable: diabetes
Tests of Normality
Kolmogorov-Smirnova
diabetes
kreatinin
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.169
15
.200*
.863
15
.027
2
.183
26
.025
.893
26
.011
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
Mann-Whitney Test
Ranks
diabetes
kreatinin
N
Mean Rank
Sum of Ranks
1
15
20.33
305.00
2
26
21.38
556.00
Total
41
Test Statisticsb
kreatinin
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
Exact Sig. [2*(1-tailed Sig.)]
185.000
305.000
-.271
.787
.799a
a. Not corrected for ties.
b. Grouping Variable: diabetes
Tests of Normality
Kolmogorov-Smirnova
diabetes
kgd
1
Statistic
.236
df
Shapiro-Wilk
Sig.
15
Statistic
.024
.840
df
Sig.
15
.013
Universitas Sumatera Utara
79
2
.179
26
.031
.899
26
.015
a. Lilliefors Significance Correction
Mann-Whitney Test
Ranks
diabetes
kgd
N
Mean Rank
Sum of Ranks
1
15
30.87
463.00
2
26
15.31
398.00
Total
41
Test Statisticsb
kgd
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
Exact Sig. [2*(1-tailed Sig.)]
47.000
398.000
-4.006
.000
.000a
a. Not corrected for ties.
b. Grouping Variable: diabetes
Report
diabetes
1
sex
Mean
HR
BMI
merokok
56.80
127.00
76.07
25.4367
1.20
15
15
15
15
15
15
Std. Deviation
.414
9.428
18.689
16.180
3.79212
.414
Mean
1.08
56.46
131.81
72.35
25.5288
1.08
N
Total
TDS
1.20
N
2
usia
26
26
26
26
26
26
Std. Deviation
.272
6.243
19.291
12.435
3.29004
.272
Mean
1.12
56.59
130.05
73.71
25.4951
1.12
N
Std. Deviation
41
41
41
41
41
41
.331
7.450
18.983
13.841
3.43516
.331
clopidogrel
statin
Report
diabetes
1
hipertensi
Mean
aspirin
1.27
1.67
1.53
1.53
1.67
15
15
15
15
15
15
Std. Deviation
.488
.458
.488
.516
.516
.488
Mean
1.27
1.65
1.77
1.58
1.65
1.77
26
26
26
26
26
26
Std. Deviation
.452
.485
.430
.504
.485
.430
Mean
1.29
1.51
1.73
1.56
1.61
1.73
41
41
41
41
41
41
.461
.506
.449
.502
.494
.449
N
Total
riwPCI
1.33
N
2
riwACS
N
Std. Deviation
Report
diabetes
hb
leukosit
platelet
ureum
Universitas Sumatera Utara
80
1
Mean
13.0467
N
2
311600.0000
37.8200
15
15
15
15
Std. Deviation
1.90108
2806.33762
1.06793E5
21.50775
Mean
14.7654
8884.2308
244000.0000
26.4731
N
Total
9518.6000
26
26
26
26
Std. Deviation
1.36057
2088.84690
45128.26165
12.12127
Mean
14.1366
9116.3171
268731.7073
30.6244
41
41
41
41
1.76759
2362.02987
79694.73772
16.86269
N
Std. Deviation
Report
diabetes
1
kreatinin
Mean
1.2047
204.9933
15
15
Std. Deviation
.51687
111.89970
Mean
1.1327
103.0192
N
2
N
Total
kgd
26
26
Std. Deviation
.31102
21.33997
Mean
1.1590
140.3268
N
Std. Deviation
41
41
.39395
84.49868
Tests of Normality
Kolmogorov-Smirnova
diabetes
TDD
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.290
15
.001
.771
15
.002
2
.167
26
.061
.924
26
.057
a. Lilliefors Significance Correction
Mann-Whitney Test
Ranks
diabetes
TDD
N
Mean Rank
Sum of Ranks
1
15
18.87
283.00
2
26
22.23
578.00
Total
41
NPar Tests
Test Statisticsb
TDD
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
163.000
283.000
-.904
.366
Universitas Sumatera Utara
81
.398a
Exact Sig. [2*(1-tailed Sig.)]
a. Not corrected for ties.
b. Grouping Variable: diabetes
Tests of Normality
Kolmogorov-Smirnova
diabetes
PT
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.131
15
.200*
.939
15
.368
2
.110
26
.200*
.946
26
.186
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
Group Statistics
diabetes
PT
N
Mean
Std. Deviation
Std. Error Mean
1
15
.9667
.09194
.02374
2
26
.9812
.08515
.01670
Independent Samples Test
Levene's Test for Equality of
Variances
F
PT
Equal variances assumed
t-test for Equality of Means
Sig.
.039
t
.845
Equal variances not assumed
df
-.510
39
-.499
27.512
Independent Samples Test
t-test for Equality of Means
Std. Error
Sig. (2-tailed)
PT
Mean Difference
Difference
Equal variances assumed
.613
-.01449
.02842
Equal variances not assumed
.622
-.01449
.02902
Independent Samples Test
Universitas Sumatera Utara
82
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
PT
Upper
Equal variances assumed
-.07197
.04299
Equal variances not assumed
-.07399
.04501
Tests of Normality
Kolmogorov-Smirnova
diabetes
APTT
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.322
15
.000
.787
15
.002
2
.122
26
.200*
.968
26
.564
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
APTT
Mann-Whitney Test
Ranks
diabetes
APTT
N
Mean Rank
Sum of Ranks
1
15
18.60
279.00
2
26
22.38
582.00
Total
41
Test Statisticsb
APTT
Mann-Whitney U
159.000
Wilcoxon W
279.000
Z
-.975
Asymp. Sig. (2-tailed)
.329
Exact Sig. [2*(1-tailed Sig.)]
.341a
a. Not corrected for ties.
b. Grouping Variable: diabetes
Tests of Normality
Universitas Sumatera Utara
83
Kolmogorov-Smirnova
diabetes
TT
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.303
15
.001
.668
15
.000
2
.134
26
.200*
.940
26
.132
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
TT
Mann-Whitney Test
Ranks
diabetes
TT
N
Mean Rank
Sum of Ranks
1
15
23.73
356.00
2
26
19.42
505.00
Total
41
Test Statisticsb
TT
Mann-Whitney U
154.000
Wilcoxon W
505.000
Z
-1.112
Asymp. Sig. (2-tailed)
.266
Exact Sig. [2*(1-tailed Sig.)]
.277a
a. Not corrected for ties.
b. Grouping Variable: diabetes
Tests of Normality
Kolmogorov-Smirnova
diabetes
TEGR
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.200
15
.110
.930
15
.274
2
.128
26
.200*
.973
26
.700
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
TEGR
Group Statistics
Universitas Sumatera Utara
84
diabetes
TEGR
N
Mean
Std. Deviation
Std. Error Mean
1
15
4.9067
1.14297
.29511
2
26
6.0808
1.52683
.29944
Independent Samples Test
Levene's Test for Equality of
Variances
F
TEGR
t-test for Equality of Means
Sig.
Equal variances assumed
t
1.519
.225
Equal variances not assumed
df
-2.584
39
-2.793
36.187
Independent Samples Test
t-test for Equality of Means
Std. Error
Sig. (2-tailed)
TEGR
Mean Difference
Difference
Equal variances assumed
.014
-1.17410
.45431
Equal variances not assumed
.008
-1.17410
.42042
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
TEGR
Upper
Equal variances assumed
-2.09304
-.25517
Equal variances not assumed
-2.02660
-.32160
Tests of Normality
Kolmogorov-Smirnova
diabetes
TEGangle
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.124
15
.200*
.978
15
.952
2
.100
26
.200*
.957
26
.340
a. Lilliefors Significance Correction
Universitas Sumatera Utara
85
Tests of Normality
Kolmogorov-Smirnova
diabetes
TEGangle
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.124
15
.200*
.978
15
.952
2
.100
26
.200*
.957
26
.340
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
TEGangle
Group Statistics
diabetes
TEGangle
N
Mean
Std. Deviation
Std. Error Mean
1
15
69.9467
5.10166
1.31724
2
26
66.0192
5.37171
1.05348
Independent Samples Test
Levene's Test for Equality of
Variances
F
TEGangle
Equal variances assumed
t-test for Equality of Means
Sig.
.155
t
.696
Equal variances not assumed
df
2.296
39
2.328
30.621
Independent Samples Test
t-test for Equality of Means
Std. Error
Sig. (2-tailed)
TEGangle
Mean Difference
Difference
Equal variances assumed
.027
3.92744
1.71078
Equal variances not assumed
.027
3.92744
1.68670
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Universitas Sumatera Utara
86
Lower
TEGangle
Upper
Equal variances assumed
.46706
7.38781
Equal variances not assumed
.48567
7.36920
Tests of Normality
Kolmogorov-Smirnova
diabetes
TEGK
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.113
15
.200*
.972
15
.889
2
.108
26
.200*
.973
26
.697
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
TEGK
Group Statistics
diabetes
TEGK
N
Mean
Std. Deviation
Std. Error Mean
1
15
1.3600
.35214
.09092
2
26
1.7769
.46674
.09154
Independent Samples Test
Levene's Test for Equality of
Variances
F
TEGK
Equal variances assumed
t-test for Equality of Means
Sig.
1.439
t
.237
Equal variances not assumed
df
-2.996
39
-3.232
36.033
Independent Samples Test
t-test for Equality of Means
Std. Error
Sig. (2-tailed)
TEGK
Mean Difference
Difference
Equal variances assumed
.005
-.41692
.13914
Equal variances not assumed
.003
-.41692
.12902
Universitas Sumatera Utara
87
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
TEGK
Upper
Equal variances assumed
-.69836
-.13548
Equal variances not assumed
-.67857
-.15527
Tests of Normality
Kolmogorov-Smirnova
diabetes
TEGMA
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.117
15
.200*
.969
15
.836
2
.149
26
.140
.965
26
.508
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
TEGMA
Group Statistics
diabetes
TEGMA
N
Mean
Std. Deviation
Std. Error Mean
1
15
69.2200
5.14215
1.32770
2
26
65.0615
5.50818
1.08024
Independent Samples Test
Levene's Test for Equality of
Variances
F
TEGMA
Equal variances assumed
t-test for Equality of Means
Sig.
.016
t
.901
Equal variances not assumed
df
2.384
39
2.430
31.051
Independent Samples Test
t-test for Equality of Means
Universitas Sumatera Utara
88
Std. Error
Sig. (2-tailed)
TEGMA
Mean Difference
Difference
Equal variances assumed
.022
4.15846
1.74427
Equal variances not assumed
.021
4.15846
1.71164
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
TEGMA
Upper
Equal variances assumed
.63034
7.68658
Equal variances not assumed
.66778
7.64914
Tests of Normality
Kolmogorov-Smirnova
diabetes
TEGG
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.152
15
.200*
.942
15
.412
2
.138
26
.200*
.945
26
.179
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
TEGG
Group Statistics
diabetes
TEGG
N
Mean
Std. Deviation
Std. Error Mean
1
15
11.7067
2.91828
.75350
2
26
9.6500
2.39136
.46898
Independent Samples Test
Levene's Test for Equality of
Variances
F
TEGG
Equal variances assumed
Equal variances not assumed
t-test for Equality of Means
Sig.
1.872
t
.179
df
2.446
39
2.317
24.859
Universitas Sumatera Utara
89
Independent Samples Test
t-test for Equality of Means
Std. Error
Sig. (2-tailed)
TEGG
Mean Difference
Difference
Equal variances assumed
.019
2.05667
.84070
Equal variances not assumed
.029
2.05667
.88753
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
TEGG
Upper
Equal variances assumed
.35620
3.75713
Equal variances not assumed
.22824
3.88509
Tests of Normality
Kolmogorov-Smirnova
diabetes
EPL
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.355
15
.000
.581
15
.000
2
.288
26
.000
.623
26
.000
a. Lilliefors Significance Correction
EPL
Mann-Whitney Test
Ranks
diabetes
EPL
N
Mean Rank
Sum of Ranks
1
15
21.93
329.00
2
26
20.46
532.00
Total
41
Test Statisticsb
EPL
Mann-Whitney U
181.000
Wilcoxon W
532.000
Universitas Sumatera Utara
90
Z
-.387
Asymp. Sig. (2-tailed)
.699
Exact Sig. [2*(1-tailed Sig.)]
.718a
a. Not corrected for ties.
b. Grouping Variable: diabetes
Descriptive Statistics
N
Minimum
Maximum
Mean
Std. Deviation
PT
41
.84
1.17
.9759
.08683
INR
41
.83
1.17
.9759
.08826
APTT
41
.58
1.73
.9546
.19818
TT
41
.71
1.62
.8888
.15012
TEGR
41
2.70
9.30
5.6512
1.49735
TEGangle
41
57.70
80.90
67.4561
5.55086
TEGK
41
.80
2.70
1.6244
.46999
TEGMA
41
53.90
77.40
66.5829
5.68590
TEGG
41
5.80
17.10
10.4024
2.74968
EPL
41
.00
11.80
1.3439
2.58041
Valid N (listwise)
41
Tests of Normality
Kolmogorov-Smirnova
diabetes
INR
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.122
15
.200*
.942
15
.411
2
.110
26
.200*
.943
26
.157
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
INR
Group Statistics
diabetes
INR
N
Mean
Std. Deviation
Std. Error Mean
1
15
.9653
.09395
.02426
2
26
.9819
.08612
.01689
Universitas Sumatera Utara
91
Independent Samples Test
Levene's Test for Equality of
Variances
F
INR
t-test for Equality of Means
Sig.
Equal variances assumed
t
.057
.812
Equal variances not assumed
df
-.575
39
-.561
27.273
Independent Samples Test
t-test for Equality of Means
Std. Error
Sig. (2-tailed)
INR
Mean Difference
Difference
Equal variances assumed
.569
-.01659
.02886
Equal variances not assumed
.579
-.01659
.02956
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
INR
Upper
Equal variances assumed
-.07496
.04178
Equal variances not assumed
-.07721
.04403
Universitas Sumatera Utara
92
LAMPIRAN 7
DAFTAR RIWAYAT HIDUP
DATA PRIBADI
Nama
: dr.Brama Ihsan Sazli
Tempat/Tgl. lahir
: Medan / 13 Agustus 1987
Jenis kelamin
: Pria
Agama
: Islam
Pekerjaan
: Dokter
NIP
:
Pangkat/Gol.
: Penata / IIIb
Alamat pekerjaan
: Fakultas Kedokteran Universitas Sumatera Utara
198708132012121003
Jl. dr. Mansyur no. 5 Medan
Departemen Ilmu Penyakit Dalam
RSUP. H. Adam Malik Medan
Jl. Bunga Lau no.17 Medan
Alamat rumah
: Jl.Gaperta No. 188
Kecamatan Medan JHelvetia
Medan
Telepon selular
: 085296630320
PENDIDIKAN
SD Swasta IKAL (1993-1998) di Medan – Sumatera Utara
SLTP Negeri 7 Medan (1998-2001) di Medan – Sumatera Utara
SMU Negeri 4 Medan (2001-2004) di Medan – Sumatera Utara
Fakultas Kedokteran USU (2004-2009) di Medan – Sumatera Utara
PPDS Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Sumatera Utara
(2011 - sekarang) di Medan-Sumatera Utara
RIWAYAT PEKERJAAN
Universitas Sumatera Utara
93
KEANGGOTAAN PROFESI
Ikatan Dokter Indonesia (IDI)
Perhimpunan Ahli Penyakit Dalam Indonesia (PAPDI)
KURSUS PENATARAN
Kursus Advanced Cardiac Life Support Course. PERKI, Medan 2010.
KARYA ILMIAH
Brama Ihsan Sazli, Halomoan Budi Santososo, Dharma Lindarto. Pengaruh Pola
Hidup Medis dengan dan tanpa Metformin Terhadap Kadar Adiponektin pada
PAsien Obesitas. SUMETSU. Surabaya. 2012
Brama Ihsan Sazli, Abdurrahim R. Lubis. Gangguan Fungsi Ginjal Pada
Keracunan Paraquat. PIT PERNEFRI. Denpasar. 2012
Universitas Sumatera Utara
LAMPIRAN 1
Universitas Sumatera Utara
62
LAMPIRAN 2
LEMBAR PENJELASAN KEPADA CALON SUBJEK PENELITIAN
Selamat pagi/siang Bapak/Ibu, pada hari ini saya, dr.Brama Ihsan Sazli,
peserta Pendidikan Pasca Sarjana Ilmu Penyakit Dalam / Magister Klinik FK
USU Medan akan melakukan penelitian yang berjudul ” Perbandingan faal
hemostasis pada pasien penyakit jantung koroner dengan dan tanpa DM tipe 2
dengan menggunakan tromboelastografi ”. Dimana faal hemostasis ini merupakan
tingkat proses pembekuan darah bapak.
Anda bebas memilih keikutsertaan dalam penelitian ini tanpa paksaan dari
pihak manapun. Bila Anda sudah memutuskan untuk ikut, Anda juga bebas untuk
mengundurkan diri/ berubah pikiran setiap saat tanpa dikenakan denda atau pun
sanksi apapun.
Apabila Anda bersedia berpartisipasi dalam penelitian ini, Anda diminta
menandatangani lembar persetujuan untuk peneliti. Prosedur selanjutnya adalah:
1. Anda akan diwawancarai oleh peneliti untuk menanyakan identitas subjek,
riwayat penyakit, riwayat obat-obatan, dan riwayat kesehatan lain yang
berhubungan dengan penelitian ini.
2. Anda akan diminta untuk dilakukan pengambilan darah sebanyak 1 kali.
Pengambilan darah dilakukan sehari setelah dilakukan prosedur.
3. Pengambilan darah akan dilakukan oleh perawat yang berkompeten dan
telah terbiasa melakukan tindakan tersebut.
4. Sampel darah akan dibawa untuk dilakukan pemeriksaan.
Sebagai subjek penelitian, Anda berkewajiban mengikuti aturan atau
petunjuk penelitian seperti yang tertulis di atas. Bila ada yang belum jelas, Anda
dapat bertanya kepada peneliti.
Pada dasarnya, pengambilan darah hanya akan menyebabkan risiko
minimal. Risiko yang mungkin terjadi adalah lebam/kulit kebiruan atau sedikit
perdarahan pada daerah tempat pengambilan darah. Anda dapat menekan daerah
suntikan jika darah masih mengalir dan mengompres daerah suntikan jika terjadi
lebam/kulit kebiruan.
Segala biaya pemeriksaan laboratorium dan penyediaan obat menjadi
tanggung jawab peneliti. Bila masih terdapat pertanyaan atau keluhan sewaktu
penelitian ini berjalan, maka Bapak/Ibu dapat menghubungi saya pada:
Nama
: dr.Brama Ihsan Sazli
Alamat
: Jl. Gaperta no 188 Medan
Telepon
: 085296630320
Peneliti,
(dr.Brama Ihsan Sazli)
Universitas Sumatera Utara
63
LAMPIRAN 3
SURAT PERSETUJUAN SETELAH PENJELASAN
(INFORMED CONCERN )
Saya yang bertanda tangan dibawah ini :
Nama
:...........................................................................................
Alamat
:...........................................................................................
Umur
:........................ Tahun
Jenis Kelamin : Laki-laki/ Perempuan.
No Telp/HP :
Setelah mendapat penjelasan dari peneliti tentang kebaikan dan keburukan
prosedur penelitian ini , menyatakan secara sadar dan tanpa paksaan bersedia ikut
serta dalam penelitian” Perbandingan faal hemostasis pada pasien Diabetes
Mellitus tipe 2 dan Penyakit Jantung Koroner dengan menggunakan
tromboelastografi”.
Demikianlah surat persetujuan bersedia ikut dalam penelitian ini saya buat, untuk
dapat digunakan seperlunya.
…........................2015
Saksi
(…..........................................)
Medan,
Yang Memberi Pernyataan
(…..........................................)
Universitas Sumatera Utara
64
LAMPIRAN 4
KERTAS KERJA PROFIL PESERTA PENELITIAN
I.IDENTITAS PRIBADI
Nama
Tempat/Tanggal Lahir
Jenis Kelamin
Pendidikan Terakhir
Pekerjaan
Status
Telp/Hp:….............
:
Kode : X / Y
:
: Laki-laki/Perempuan.
:
:
:
Kawin/Belum
Kawin.
No
II.ANAMNESIS PENYAKIT DAN PENGOBATAN
Anamnesis Penyakit dan Terapi
1. Diabetes Mellitus / dalam terapi Diabetes mellitus
2. Hipertensi, kardiovaskular dan stroke
3. Penyakit kronis
4. Penyakit gangguan fungsi ginjal
5. Penyakit gangguan fungsi hati
6. Hamil/Menyusui/Terapi Hormonal
7. Perokok.
Ya
Tidak
III.PEMERIKSAAN FISIK
Tekanan Darah
: ….... mmHg.
Pemeriksaan Parameter Antrometri.
Parameter Antropometri
Berat Badan (kg)
Tinggi Badan (m2)
Indeks Massa Tubuh (kg/m2 )
Pre- Test
Post-Test
IV.PEMERIKSAAN LABORATORIUM
Rutin:
Hemostasis Konvensional:
V. Hasil Tromboelastografi:
Universitas Sumatera Utara
65
LAMPIRAN 5
Data Penelitian
Universitas Sumatera Utara
66
Keterangan:
Jenis Kelamin: 1: laki-laki
2: Wanita
Obese, Merokok, Dislipidemia, HT, Diabetes, riwayat keluarga, riwayat ACS,
Aspirin, Clopidogrel, Statin:
1: ya
2: tidak
Universitas Sumatera Utara
67
LAMPIRAN 6
Output Analisis
Tests of Normality
Kolmogorov-Smirnova
diabetes
usia
Statistic
1
df
.109
2
Shapiro-Wilk
Sig.
15
.120
26
Statistic
df
Sig.
.200
*
.972
15
.888
.200
*
.963
26
.461
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
Group Statistics
diabetes
usia
N
Mean
Std. Deviation
Std. Error Mean
1
15
56.80
9.428
2.434
2
26
56.46
6.243
1.224
Independent Samples Test
Levene's Test for Equality of
Variances
F
usia
t-test for Equality of Means
Sig.
Equal variances assumed
t
3.006
.091
Equal variances not assumed
df
.138
39
.124
21.219
Independent Samples Test
t-test for Equality of Means
Sig. (2-tailed)
usia
Mean Difference
Std. Error
Difference
Equal variances assumed
.891
.338
2.446
Equal variances not assumed
.902
.338
2.725
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
usia
Upper
Equal variances assumed
-4.608
5.285
Equal variances not assumed
-5.325
6.002
Crosstabs
sex * diabetes Crosstabulation
diabetes
1
2
Total
Universitas Sumatera Utara
68
sex
1
Count
Expected Count
2
12
24
36
13.2
22.8
36.0
3
2
5
1.8
3.2
5.0
Count
Expected Count
Total
Count
Expected Count
15
26
41
15.0
26.0
41.0
Chi-Square Tests
Value
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
Asymp. Sig. (2sided)
df
1.346a
.442
1.291
1
1
1
.246
.506
.256
1.313
41
1
.252
Exact Sig. (2sided)
Exact Sig. (1sided)
.336
.249
a. 2 cells (50,0%) have expected count less than 5. The minimum expected count is 1,83.
b. Computed only for a 2x2 table
Explore
Tests of Normality
Kolmogorov-Smirnova
diabetes
TDS
Statistic
df
Shapiro-Wilk
Sig.
1
.179
15
2
.191
26
Statistic
df
Sig.
*
.946
15
.460
.015
.933
26
.093
.200
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
T-Test
Group Statistics
diabetes
TDS
N
Mean
Std. Deviation
Std. Error Mean
1
15
127.00
18.689
4.826
2
26
131.81
19.291
3.783
Independent Samples Test
Levene's Test for Equality of
Variances
F
TDS
Equal variances assumed
t-test for Equality of Means
Sig.
.003
t
.959
Equal variances not assumed
df
-.777
39
-.784
30.127
Independent Samples Test
t-test for Equality of Means
Universitas Sumatera Utara
69
Sig. (2-tailed)
TDS
Std. Error
Difference
Mean Difference
Equal variances assumed
.442
-4.808
6.186
Equal variances not assumed
.439
-4.808
6.132
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
TDS
Upper
Equal variances assumed
-17.319
7.704
Equal variances not assumed
-17.328
7.713
Explore
diabetes
Tests of Normality
Kolmogorov-Smirnova
diabetes
HR
Statistic
1
df
.217
2
Shapiro-Wilk
Sig.
.113
Statistic
df
Sig.
15
.055
.843
15
.014
26
*
.963
26
.458
.200
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
Mann-Whitney Test
Ranks
iabetes
HR
N
Mean Rank
Sum of Ranks
1
15
21.93
329.00
2
26
20.46
532.00
Total
41
Test Statisticsb
HR
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
Exact Sig. [2*(1-tailed Sig.)]
181.000
532.000
-.380
.704
.718a
a. Not corrected for ties.
b. Grouping Variable: diabetes
Explore
Tests of Normality
Kolmogorov-Smirnova
diabetes
BMI
1
Statistic
.138
df
Shapiro-Wilk
Sig.
15
.200
Statistic
*
.918
df
Sig.
15
.178
Universitas Sumatera Utara
70
2
.123
.200*
26
.943
26
.160
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
T-Test
Group Statistics
diabetes
BMI
N
Mean
Std. Deviation
Std. Error Mean
1
15
25.4367
3.79212
.97912
2
26
25.5288
3.29004
.64523
Independent Samples Test
Levene's Test for Equality of
Variances
F
BMI
t-test for Equality of Means
Sig.
Equal variances assumed
t
.287
.595
Equal variances not assumed
df
-.082
39
-.079
26.049
Independent Samples Test
t-test for Equality of Means
Sig. (2-tailed)
BMI
Std. Error
Difference
Mean Difference
Equal variances assumed
.935
-.09218
1.12789
Equal variances not assumed
.938
-.09218
1.17260
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
BMI
Upper
Equal variances assumed
-2.37355
2.18919
Equal variances not assumed
-2.50228
2.31792
merokok * diabetes Crosstabulation
diabetes
1
Merokok
1
Count
Total
Total
12
24
36
13.2
22.8
36.0
3
2
5
Expected Count
1.8
3.2
5.0
Count
15
26
41
15.0
26.0
41.0
Expected Count
2
2
Count
Expected Count
Chi-Square Tests
Universitas Sumatera Utara
71
Value
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
Asymp. Sig. (2sided)
df
Exact Sig. (2sided)
1.346a
.442
1.291
1
1
1
.246
.506
.256
1.313
41
1
.252
Exact Sig. (1sided)
.336
.249
a. 2 cells (50,0%) have expected count less than 5. The minimum expected count is 1,83.
b. Computed only for a 2x2 table
hipertensi * diabetes Crosstabulation
diabetes
1
hipertensi
1
Count
Total
Total
19
29
10.6
18.4
29.0
5
7
12
Expected Count
4.4
7.6
12.0
Count
15
26
41
15.0
26.0
41.0
Expected Count
2
2
10
Count
Expected Count
Chi-Square Tests
Value
.189a
.006
.187
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
Asymp. Sig. (2sided)
df
1
1
1
Exact Sig. (2sided)
Exact Sig. (1sided)
.664
.938
.665
.730
.184
41
1
.668
a. 1 cells (25,0%) have expected count less than 5. The minimum expected count is 4,39.
b. Computed only for a 2x2 table
NPar Tests
Two-Sample Kolmogorov-Smirnov Test
Frequencies
diabetes
Merokok
N
1
15
2
26
Total
41
Test Statisticsa
merokok
Most Extreme Differences
Absolute
.123
Positive
.123
Universitas Sumatera Utara
.464
72
Negative
Kolmogorov-Smirnov Z
.000
.380
Asymp. Sig. (2-tailed)
.999
a. Grouping Variable: diabetes
NPar Tests
Two-Sample Kolmogorov-Smirnov Test
Frequencies
diabetes
Hipertensi
N
1
15
2
26
Total
41
Test Statisticsa
hipertensi
Most Extreme Differences
Absolute
.064
Positive
.064
Negative
Kolmogorov-Smirnov Z
.000
.198
Asymp. Sig. (2-tailed)
1.000
a. Grouping Variable: diabetes
riwACS * diabetes Crosstabulation
diabetes
1
riwACS
1
2
Total
2
Total
Count
11
9
20
Expected Count
7.3
12.7
20.0
4
17
21
Expected Count
7.7
13.3
21.0
Count
15
26
41
15.0
26.0
41.0
Count
Expected Count
Chi-Square Tests
Value
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
5.707a
4.263
5.874
Asymp. Sig. (2sided)
df
1
1
1
Exact Sig. (2sided)
Exact Sig. (1sided)
.017
.039
.015
.025
5.568
41
1
.018
a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 7,32.
b. Computed only for a 2x2 table
riwPCI * diabetes Crosstabulation
Universitas Sumatera Utara
.019
73
diabetes
1
riwPCI
1
2
Count
Total
5
6
11
Expected Count
4.0
7.0
11.0
Count
10
20
30
11.0
19.0
30.0
15
26
41
15.0
26.0
41.0
Expected Count
Total
2
Count
Expected Count
Chi-Square Tests
Value
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
Asymp. Sig. (2sided)
df
Exact Sig. (2sided)
.510a
.121
.501
1
1
1
.475
.728
.479
.497
41
1
.481
Exact Sig. (1sided)
.491
a. 1 cells (25,0%) have expected count less than 5. The minimum expected count is 4,02.
b. Computed only for a 2x2 table
NPar Tests
Two-Sample Kolmogorov-Smirnov Test
Frequencies
diabetes
riwPCI
N
1
15
2
26
Total
41
Test Statisticsa
riwPCI
Most Extreme Differences
Absolute
.103
Positive
.000
Negative
Kolmogorov-Smirnov Z
-.103
.316
Asymp. Sig. (2-tailed)
1.000
a. Grouping Variable: diabetes
aspirin * diabetes Crosstabulation
diabetes
1
aspirin
1
Count
Expected Count
2
Count
2
Total
7
11
18
6.6
11.4
18.0
8
15
23
Universitas Sumatera Utara
.359
74
Total
Expected Count
8.4
14.6
23.0
Count
15
26
41
15.0
26.0
41.0
Expected Count
Chi-Square Tests
Value
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
Asymp. Sig. (2sided)
df
Exact Sig. (2sided)
.073a
.000
.073
1
1
1
.786
1.000
.787
.072
41
1
.789
Exact Sig. (1sided)
1.000
.521
a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 6,59.
b. Computed only for a 2x2 table
Crosstabs
Case Processing Summary
Cases
Valid
N
clopidogrel * diabetes
Missing
Percent
41
N
100.0%
Total
Percent
N
0
.0%
2
Total
Percent
41
100.0%
clopidogrel * diabetes Crosstabulation
diabetes
1
clopidogrel
1
Count
Expected Count
2
Total
7
9
16
5.9
10.1
16.0
Count
8
17
25
Expected Count
9.1
15.9
25.0
Count
15
26
41
15.0
26.0
41.0
Expected Count
Chi-Square Tests
Value
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
Asymp. Sig. (2sided)
df
.581a
.185
.577
1
1
1
.446
.667
.448
.566
41
1
.452
Exact Sig. (2sided)
Exact Sig. (1sided)
.517
a. 0 cells (,0%) have expected count less than 5. The minimum expected count is 5,85.
b. Computed only for a 2x2 table
Universitas Sumatera Utara
.332
75
statin * diabetes Crosstabulation
diabetes
1
statin
1
2
Total
5
6
11
Expected Count
4.0
7.0
11.0
Count
10
20
30
11.0
19.0
30.0
Expected Count
Total
2
Count
Count
Expected Count
15
26
41
15.0
26.0
41.0
Chi-Square Tests
Value
Asymp. Sig. (2sided)
df
.510a
.121
.501
Pearson Chi-Square
Continuity Correctionb
Likelihood Ratio
Fisher's Exact Test
Linear-by-Linear Association
N of Valid Cases
1
1
1
Exact Sig. (2sided)
Exact Sig. (1sided)
.475
.728
.479
.491
.497
41
1
.359
.481
a. 1 cells (25,0%) have expected count less than 5. The minimum expected count is 4,02.
b. Computed only for a 2x2 table
Tests of Normality
Kolmogorov-Smirnova
diabetes
hb
Statistic
1
df
.160
2
Shapiro-Wilk
Sig.
15
.101
26
Statistic
df
Sig.
.200
*
.918
15
.178
.200
*
.963
26
.444
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
T-Test
Group Statistics
diabetes
hb
N
Mean
Std. Deviation
Std. Error Mean
1
15
13.0467
1.90108
.49086
2
26
14.7654
1.36057
.26683
Independent Samples Test
Levene's Test for Equality of
Variances
F
hb
Equal variances assumed
t-test for Equality of Means
Sig.
3.034
Equal variances not assumed
t
.089
df
-3.363
39
-3.076
22.401
Independent Samples Test
Universitas Sumatera Utara
76
t-test for Equality of Means
Sig. (2-tailed)
hb
Std. Error
Difference
Mean Difference
Equal variances assumed
.002
-1.71872
.51102
Equal variances not assumed
.005
-1.71872
.55869
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
hb
Upper
Equal variances assumed
-2.75235
-.68509
Equal variances not assumed
-2.87617
-.56126
Tests of Normality
Kolmogorov-Smirnova
diabetes
leukosit
Statistic
df
Shapiro-Wilk
Sig.
1
.169
15
2
.153
26
Statistic
df
Sig.
*
.929
15
.261
.118
.908
26
.024
.200
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
Mann-Whitney Test
Ranks
diabetes
leukosit
N
Mean Rank
Sum of Ranks
1
15
22.20
333.00
2
26
20.31
528.00
Total
41
Test Statisticsb
leukosit
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
Exact Sig. [2*(1-tailed Sig.)]
177.000
528.000
-.487
.626
.640a
a. Not corrected for ties.
b. Grouping Variable: diabetes
Tests of Normality
Kolmogorov-Smirnova
diabetes
platelet
1
Statistic
.151
df
Shapiro-Wilk
Sig.
15
.200
Statistic
*
df
.910
Sig.
15
.133
Universitas Sumatera Utara
77
2
.130
.200*
26
.968
26
.583
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
Group Statistics
diabetes
platelet
N
Mean
Std. Deviation
Std. Error Mean
1
15
311600.0000
1.06793E5
27573.93524
2
26
244000.0000
45128.26165
8850.38026
Independent Samples Test
Levene's Test for Equality of
Variances
F
platelet
Equal variances assumed
t-test for Equality of Means
Sig.
19.328
t
.000
Equal variances not assumed
df
2.837
39
2.334
16.933
Independent Samples Test
t-test for Equality of Means
Sig. (2-tailed)
platelet
Mean Difference
Std. Error
Difference
Equal variances assumed
.007
67600.00000
23825.25359
Equal variances not assumed
.032
67600.00000
28959.47402
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
platelet
Equal variances assumed
Equal variances not assumed
Upper
19408.87589
1.15791E5
6482.30258
1.28718E5
diabetes
Tests of Normality
Kolmogorov-Smirnova
diabetes
ureum
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.236
15
.025
.815
15
.006
2
.183
26
.024
.865
26
.003
a. Lilliefors Significance Correction
Mann-Whitney Test
Ranks
diabetes
ureum
N
Mean Rank
Sum of Ranks
1
15
25.77
386.50
2
26
18.25
474.50
Universitas Sumatera Utara
78
Ranks
diabetes
ureum
N
Mean Rank
Sum of Ranks
1
15
25.77
386.50
2
26
18.25
474.50
Total
41
Test Statisticsb
ureum
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
Exact Sig. [2*(1-tailed Sig.)]
123.500
474.500
-1.935
.053
.052a
a. Not corrected for ties.
b. Grouping Variable: diabetes
Tests of Normality
Kolmogorov-Smirnova
diabetes
kreatinin
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.169
15
.200*
.863
15
.027
2
.183
26
.025
.893
26
.011
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
Mann-Whitney Test
Ranks
diabetes
kreatinin
N
Mean Rank
Sum of Ranks
1
15
20.33
305.00
2
26
21.38
556.00
Total
41
Test Statisticsb
kreatinin
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
Exact Sig. [2*(1-tailed Sig.)]
185.000
305.000
-.271
.787
.799a
a. Not corrected for ties.
b. Grouping Variable: diabetes
Tests of Normality
Kolmogorov-Smirnova
diabetes
kgd
1
Statistic
.236
df
Shapiro-Wilk
Sig.
15
Statistic
.024
.840
df
Sig.
15
.013
Universitas Sumatera Utara
79
2
.179
26
.031
.899
26
.015
a. Lilliefors Significance Correction
Mann-Whitney Test
Ranks
diabetes
kgd
N
Mean Rank
Sum of Ranks
1
15
30.87
463.00
2
26
15.31
398.00
Total
41
Test Statisticsb
kgd
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
Exact Sig. [2*(1-tailed Sig.)]
47.000
398.000
-4.006
.000
.000a
a. Not corrected for ties.
b. Grouping Variable: diabetes
Report
diabetes
1
sex
Mean
HR
BMI
merokok
56.80
127.00
76.07
25.4367
1.20
15
15
15
15
15
15
Std. Deviation
.414
9.428
18.689
16.180
3.79212
.414
Mean
1.08
56.46
131.81
72.35
25.5288
1.08
N
Total
TDS
1.20
N
2
usia
26
26
26
26
26
26
Std. Deviation
.272
6.243
19.291
12.435
3.29004
.272
Mean
1.12
56.59
130.05
73.71
25.4951
1.12
N
Std. Deviation
41
41
41
41
41
41
.331
7.450
18.983
13.841
3.43516
.331
clopidogrel
statin
Report
diabetes
1
hipertensi
Mean
aspirin
1.27
1.67
1.53
1.53
1.67
15
15
15
15
15
15
Std. Deviation
.488
.458
.488
.516
.516
.488
Mean
1.27
1.65
1.77
1.58
1.65
1.77
26
26
26
26
26
26
Std. Deviation
.452
.485
.430
.504
.485
.430
Mean
1.29
1.51
1.73
1.56
1.61
1.73
41
41
41
41
41
41
.461
.506
.449
.502
.494
.449
N
Total
riwPCI
1.33
N
2
riwACS
N
Std. Deviation
Report
diabetes
hb
leukosit
platelet
ureum
Universitas Sumatera Utara
80
1
Mean
13.0467
N
2
311600.0000
37.8200
15
15
15
15
Std. Deviation
1.90108
2806.33762
1.06793E5
21.50775
Mean
14.7654
8884.2308
244000.0000
26.4731
N
Total
9518.6000
26
26
26
26
Std. Deviation
1.36057
2088.84690
45128.26165
12.12127
Mean
14.1366
9116.3171
268731.7073
30.6244
41
41
41
41
1.76759
2362.02987
79694.73772
16.86269
N
Std. Deviation
Report
diabetes
1
kreatinin
Mean
1.2047
204.9933
15
15
Std. Deviation
.51687
111.89970
Mean
1.1327
103.0192
N
2
N
Total
kgd
26
26
Std. Deviation
.31102
21.33997
Mean
1.1590
140.3268
N
Std. Deviation
41
41
.39395
84.49868
Tests of Normality
Kolmogorov-Smirnova
diabetes
TDD
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.290
15
.001
.771
15
.002
2
.167
26
.061
.924
26
.057
a. Lilliefors Significance Correction
Mann-Whitney Test
Ranks
diabetes
TDD
N
Mean Rank
Sum of Ranks
1
15
18.87
283.00
2
26
22.23
578.00
Total
41
NPar Tests
Test Statisticsb
TDD
Mann-Whitney U
Wilcoxon W
Z
Asymp. Sig. (2-tailed)
163.000
283.000
-.904
.366
Universitas Sumatera Utara
81
.398a
Exact Sig. [2*(1-tailed Sig.)]
a. Not corrected for ties.
b. Grouping Variable: diabetes
Tests of Normality
Kolmogorov-Smirnova
diabetes
PT
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.131
15
.200*
.939
15
.368
2
.110
26
.200*
.946
26
.186
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
Group Statistics
diabetes
PT
N
Mean
Std. Deviation
Std. Error Mean
1
15
.9667
.09194
.02374
2
26
.9812
.08515
.01670
Independent Samples Test
Levene's Test for Equality of
Variances
F
PT
Equal variances assumed
t-test for Equality of Means
Sig.
.039
t
.845
Equal variances not assumed
df
-.510
39
-.499
27.512
Independent Samples Test
t-test for Equality of Means
Std. Error
Sig. (2-tailed)
PT
Mean Difference
Difference
Equal variances assumed
.613
-.01449
.02842
Equal variances not assumed
.622
-.01449
.02902
Independent Samples Test
Universitas Sumatera Utara
82
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
PT
Upper
Equal variances assumed
-.07197
.04299
Equal variances not assumed
-.07399
.04501
Tests of Normality
Kolmogorov-Smirnova
diabetes
APTT
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.322
15
.000
.787
15
.002
2
.122
26
.200*
.968
26
.564
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
APTT
Mann-Whitney Test
Ranks
diabetes
APTT
N
Mean Rank
Sum of Ranks
1
15
18.60
279.00
2
26
22.38
582.00
Total
41
Test Statisticsb
APTT
Mann-Whitney U
159.000
Wilcoxon W
279.000
Z
-.975
Asymp. Sig. (2-tailed)
.329
Exact Sig. [2*(1-tailed Sig.)]
.341a
a. Not corrected for ties.
b. Grouping Variable: diabetes
Tests of Normality
Universitas Sumatera Utara
83
Kolmogorov-Smirnova
diabetes
TT
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.303
15
.001
.668
15
.000
2
.134
26
.200*
.940
26
.132
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
TT
Mann-Whitney Test
Ranks
diabetes
TT
N
Mean Rank
Sum of Ranks
1
15
23.73
356.00
2
26
19.42
505.00
Total
41
Test Statisticsb
TT
Mann-Whitney U
154.000
Wilcoxon W
505.000
Z
-1.112
Asymp. Sig. (2-tailed)
.266
Exact Sig. [2*(1-tailed Sig.)]
.277a
a. Not corrected for ties.
b. Grouping Variable: diabetes
Tests of Normality
Kolmogorov-Smirnova
diabetes
TEGR
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.200
15
.110
.930
15
.274
2
.128
26
.200*
.973
26
.700
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
TEGR
Group Statistics
Universitas Sumatera Utara
84
diabetes
TEGR
N
Mean
Std. Deviation
Std. Error Mean
1
15
4.9067
1.14297
.29511
2
26
6.0808
1.52683
.29944
Independent Samples Test
Levene's Test for Equality of
Variances
F
TEGR
t-test for Equality of Means
Sig.
Equal variances assumed
t
1.519
.225
Equal variances not assumed
df
-2.584
39
-2.793
36.187
Independent Samples Test
t-test for Equality of Means
Std. Error
Sig. (2-tailed)
TEGR
Mean Difference
Difference
Equal variances assumed
.014
-1.17410
.45431
Equal variances not assumed
.008
-1.17410
.42042
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
TEGR
Upper
Equal variances assumed
-2.09304
-.25517
Equal variances not assumed
-2.02660
-.32160
Tests of Normality
Kolmogorov-Smirnova
diabetes
TEGangle
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.124
15
.200*
.978
15
.952
2
.100
26
.200*
.957
26
.340
a. Lilliefors Significance Correction
Universitas Sumatera Utara
85
Tests of Normality
Kolmogorov-Smirnova
diabetes
TEGangle
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.124
15
.200*
.978
15
.952
2
.100
26
.200*
.957
26
.340
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
TEGangle
Group Statistics
diabetes
TEGangle
N
Mean
Std. Deviation
Std. Error Mean
1
15
69.9467
5.10166
1.31724
2
26
66.0192
5.37171
1.05348
Independent Samples Test
Levene's Test for Equality of
Variances
F
TEGangle
Equal variances assumed
t-test for Equality of Means
Sig.
.155
t
.696
Equal variances not assumed
df
2.296
39
2.328
30.621
Independent Samples Test
t-test for Equality of Means
Std. Error
Sig. (2-tailed)
TEGangle
Mean Difference
Difference
Equal variances assumed
.027
3.92744
1.71078
Equal variances not assumed
.027
3.92744
1.68670
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Universitas Sumatera Utara
86
Lower
TEGangle
Upper
Equal variances assumed
.46706
7.38781
Equal variances not assumed
.48567
7.36920
Tests of Normality
Kolmogorov-Smirnova
diabetes
TEGK
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.113
15
.200*
.972
15
.889
2
.108
26
.200*
.973
26
.697
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
TEGK
Group Statistics
diabetes
TEGK
N
Mean
Std. Deviation
Std. Error Mean
1
15
1.3600
.35214
.09092
2
26
1.7769
.46674
.09154
Independent Samples Test
Levene's Test for Equality of
Variances
F
TEGK
Equal variances assumed
t-test for Equality of Means
Sig.
1.439
t
.237
Equal variances not assumed
df
-2.996
39
-3.232
36.033
Independent Samples Test
t-test for Equality of Means
Std. Error
Sig. (2-tailed)
TEGK
Mean Difference
Difference
Equal variances assumed
.005
-.41692
.13914
Equal variances not assumed
.003
-.41692
.12902
Universitas Sumatera Utara
87
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
TEGK
Upper
Equal variances assumed
-.69836
-.13548
Equal variances not assumed
-.67857
-.15527
Tests of Normality
Kolmogorov-Smirnova
diabetes
TEGMA
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.117
15
.200*
.969
15
.836
2
.149
26
.140
.965
26
.508
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
TEGMA
Group Statistics
diabetes
TEGMA
N
Mean
Std. Deviation
Std. Error Mean
1
15
69.2200
5.14215
1.32770
2
26
65.0615
5.50818
1.08024
Independent Samples Test
Levene's Test for Equality of
Variances
F
TEGMA
Equal variances assumed
t-test for Equality of Means
Sig.
.016
t
.901
Equal variances not assumed
df
2.384
39
2.430
31.051
Independent Samples Test
t-test for Equality of Means
Universitas Sumatera Utara
88
Std. Error
Sig. (2-tailed)
TEGMA
Mean Difference
Difference
Equal variances assumed
.022
4.15846
1.74427
Equal variances not assumed
.021
4.15846
1.71164
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
TEGMA
Upper
Equal variances assumed
.63034
7.68658
Equal variances not assumed
.66778
7.64914
Tests of Normality
Kolmogorov-Smirnova
diabetes
TEGG
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.152
15
.200*
.942
15
.412
2
.138
26
.200*
.945
26
.179
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
TEGG
Group Statistics
diabetes
TEGG
N
Mean
Std. Deviation
Std. Error Mean
1
15
11.7067
2.91828
.75350
2
26
9.6500
2.39136
.46898
Independent Samples Test
Levene's Test for Equality of
Variances
F
TEGG
Equal variances assumed
Equal variances not assumed
t-test for Equality of Means
Sig.
1.872
t
.179
df
2.446
39
2.317
24.859
Universitas Sumatera Utara
89
Independent Samples Test
t-test for Equality of Means
Std. Error
Sig. (2-tailed)
TEGG
Mean Difference
Difference
Equal variances assumed
.019
2.05667
.84070
Equal variances not assumed
.029
2.05667
.88753
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
TEGG
Upper
Equal variances assumed
.35620
3.75713
Equal variances not assumed
.22824
3.88509
Tests of Normality
Kolmogorov-Smirnova
diabetes
EPL
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.355
15
.000
.581
15
.000
2
.288
26
.000
.623
26
.000
a. Lilliefors Significance Correction
EPL
Mann-Whitney Test
Ranks
diabetes
EPL
N
Mean Rank
Sum of Ranks
1
15
21.93
329.00
2
26
20.46
532.00
Total
41
Test Statisticsb
EPL
Mann-Whitney U
181.000
Wilcoxon W
532.000
Universitas Sumatera Utara
90
Z
-.387
Asymp. Sig. (2-tailed)
.699
Exact Sig. [2*(1-tailed Sig.)]
.718a
a. Not corrected for ties.
b. Grouping Variable: diabetes
Descriptive Statistics
N
Minimum
Maximum
Mean
Std. Deviation
PT
41
.84
1.17
.9759
.08683
INR
41
.83
1.17
.9759
.08826
APTT
41
.58
1.73
.9546
.19818
TT
41
.71
1.62
.8888
.15012
TEGR
41
2.70
9.30
5.6512
1.49735
TEGangle
41
57.70
80.90
67.4561
5.55086
TEGK
41
.80
2.70
1.6244
.46999
TEGMA
41
53.90
77.40
66.5829
5.68590
TEGG
41
5.80
17.10
10.4024
2.74968
EPL
41
.00
11.80
1.3439
2.58041
Valid N (listwise)
41
Tests of Normality
Kolmogorov-Smirnova
diabetes
INR
Statistic
df
Shapiro-Wilk
Sig.
Statistic
df
Sig.
1
.122
15
.200*
.942
15
.411
2
.110
26
.200*
.943
26
.157
a. Lilliefors Significance Correction
*. This is a lower bound of the true significance.
INR
Group Statistics
diabetes
INR
N
Mean
Std. Deviation
Std. Error Mean
1
15
.9653
.09395
.02426
2
26
.9819
.08612
.01689
Universitas Sumatera Utara
91
Independent Samples Test
Levene's Test for Equality of
Variances
F
INR
t-test for Equality of Means
Sig.
Equal variances assumed
t
.057
.812
Equal variances not assumed
df
-.575
39
-.561
27.273
Independent Samples Test
t-test for Equality of Means
Std. Error
Sig. (2-tailed)
INR
Mean Difference
Difference
Equal variances assumed
.569
-.01659
.02886
Equal variances not assumed
.579
-.01659
.02956
Independent Samples Test
t-test for Equality of Means
95% Confidence Interval of the
Difference
Lower
INR
Upper
Equal variances assumed
-.07496
.04178
Equal variances not assumed
-.07721
.04403
Universitas Sumatera Utara
92
LAMPIRAN 7
DAFTAR RIWAYAT HIDUP
DATA PRIBADI
Nama
: dr.Brama Ihsan Sazli
Tempat/Tgl. lahir
: Medan / 13 Agustus 1987
Jenis kelamin
: Pria
Agama
: Islam
Pekerjaan
: Dokter
NIP
:
Pangkat/Gol.
: Penata / IIIb
Alamat pekerjaan
: Fakultas Kedokteran Universitas Sumatera Utara
198708132012121003
Jl. dr. Mansyur no. 5 Medan
Departemen Ilmu Penyakit Dalam
RSUP. H. Adam Malik Medan
Jl. Bunga Lau no.17 Medan
Alamat rumah
: Jl.Gaperta No. 188
Kecamatan Medan JHelvetia
Medan
Telepon selular
: 085296630320
PENDIDIKAN
SD Swasta IKAL (1993-1998) di Medan – Sumatera Utara
SLTP Negeri 7 Medan (1998-2001) di Medan – Sumatera Utara
SMU Negeri 4 Medan (2001-2004) di Medan – Sumatera Utara
Fakultas Kedokteran USU (2004-2009) di Medan – Sumatera Utara
PPDS Ilmu Penyakit Dalam Fakultas Kedokteran Universitas Sumatera Utara
(2011 - sekarang) di Medan-Sumatera Utara
RIWAYAT PEKERJAAN
Universitas Sumatera Utara
93
KEANGGOTAAN PROFESI
Ikatan Dokter Indonesia (IDI)
Perhimpunan Ahli Penyakit Dalam Indonesia (PAPDI)
KURSUS PENATARAN
Kursus Advanced Cardiac Life Support Course. PERKI, Medan 2010.
KARYA ILMIAH
Brama Ihsan Sazli, Halomoan Budi Santososo, Dharma Lindarto. Pengaruh Pola
Hidup Medis dengan dan tanpa Metformin Terhadap Kadar Adiponektin pada
PAsien Obesitas. SUMETSU. Surabaya. 2012
Brama Ihsan Sazli, Abdurrahim R. Lubis. Gangguan Fungsi Ginjal Pada
Keracunan Paraquat. PIT PERNEFRI. Denpasar. 2012
Universitas Sumatera Utara